Uploaded August 2025 | Updated September 2026, 2 weeks ago
Donate to PCRI: pcri.org/donate
For more information, visit pcri.org
0:41 What are the differences between a random needle and a targeted biopsy?
2:34 Where would someone get a targeted biopsy?
3:48 How can patients request targeted biopsies from their urologists?
5:38 How does a trans-rectal biopsy compare to a trans-perineal one?
7:51 Can patients getting targeted biopsies opt out of random needle biopsies?
8:52 What are the different types of targeted biopsy?
11:57 What is the difference in efficacy between types of biopsy?
12:37 What qualifies a doctor as being proficient at giving biopsies?
13:45 Are centers of excellence more likely to offer all types of biopsies?
14:12 Can patients undergoing a clinical trial opt out of a needle biopsy?
15:07 What forms of insurance tend to cover targeted biopsies?
15:50 Can patients get an MRI covered if they haven’t had a needle biopsy?
16:20 What should patients without as much access to centers of excellence do?
17:13 Alex’s conclusions
Don't know your stage? Take the quiz: visit prostatecancerstaging.org
To learn more about prostate cancer, visit pcri.org
Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: pcri.org/join
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
Donate to PCRI: pcri.org/donate
For more information, visit pcri.org
0:41 What are the differences between a random needle and a targeted biopsy?
2:34 Where would someone get a targeted biopsy?
3:48 How can patients request targeted biopsies from their urologists?
5:38 How does a trans-rectal biopsy compare to a trans-perineal one?
7:51 Can patients getting targeted biopsies opt out of random needle biopsies?
8:52 What are the different types of targeted biopsy?
11:57 What is the difference in efficacy between types of biopsy?
12:37 What qualifies a doctor as being proficient at giving biopsies?
13:45 Are centers of excellence more likely to offer all types of biopsies?
14:12 Can patients undergoing a clinical trial opt out of a needle biopsy?
15:07 What forms of insurance tend to cover targeted biopsies?
15:50 Can patients get an MRI covered if they haven’t had a needle biopsy?
16:20 What should patients without as much access to centers of excellence do?
17:13 Alex’s conclusions
Don't know your stage? Take the quiz: visit prostatecancerstaging.org
To learn more about prostate cancer, visit pcri.org
Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: pcri.org/join
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
